The decisions taken by the Indian leadership to straighten the curved line of Kovid-19, that is, to stop the growing infection of the corona virus, should be appreciated. When the situation is well and trench, then the step is taken thinking how to avoid the worst situation? The valuable time we have got by extending the lockdown deadline, it will definitely be used in the preparation ahead. But what is the preparation? For a defensive war or for an aggressive war? Defensive warfare would be fought through socio-political measures, such as lockdown and care for vulnerable sections, but aggressive warfare would be won by science and technology. 
Well-known health policy scholar Harvey Fineberg has suggested six major measures to prevent increasing losses from Kovid-19 in the US — first, the establishment of a clear command system. Second, broadly test, ie investigation. Third, providing adequate safety equipment to health workers and preparing the hospital to suit the increasing number of patients. Fourth, keeping a record of who is infected, who can be infected, who is unrecognized or who is now fully recovered? Fifth, motivating the common people and keeping them united. And last, continuously improve strategy by learning from research.
These six principles apply equally to India or any other country fighting the battle of Kovid-19, but all countries have their own difficulties with each measure. From the point of view of India, the command system is also active here and the public is also cooperating, but the tests are decreasing here. Again, the squares have not been determined here as per the fourth measure. The supply chain of safety equipment and goods in hospitals is also weak here. Therefore, the sixth measure, which is research-related, will not only have to deal with all these challenges, but also to wage a full-blown aggressive war against SARS-Cove 2 (Kovid-19). Obviously, we have to adopt innovative methods at every step.
Since the challenges are serious, the shared response of industry and academia in this difficult time is commendable. As such, the need for a test-kit for extensive testing. When the global supply of this kit and its accessories began to decrease, Indian industry and startups started preparing indigenous kits. A strategy is also being chalked out to gather maximum information about infection by conducting less tests. Taking advantage of the country’s existing digital and telecom infrastructure, the Arogya Setu app has been launched, which is a technical option for testing. Earlier investments in high-quality research are also giving positive results. For example, success in making crisper-based paper-strip tests. This is not only relatively inexpensive, but will also eliminate the need for PCR machines in the coming days. We got this success because,
Of course new market access is not easy. It is difficult to find materials for the crisper test at the moment. But to overcome these obstacles, a strong coalition of education industry is working well. Meanwhile, several CSIR and DBT research laboratories across the country are continuously helping the health sector by ensuring extensive RT-PCR tests. New companies are coming up with inexpensive and simple investigation system. These companies are also providing practical help in expanding the scope of investigation and effectively determining local and personal risks.
There is also a great need to overcome the challenges of personal protective equipment (PPE), hospital beds, oxygen, ventilators and new anti-viral drugs. In this context, entities like CSIR and DRDO are using each other’s laboratories to ensure the necessary supply of products. When the non-availability of seam sealing tape disrupted the production of virus-protecting suits, the option of sealant glue used for submarine equipment was adopted, to produce larger quantities of virus-protection suits. To ensure the safety of frontline health workers. Similarly, indigenous oxygen concentrator machine is being developed in collaboration with CSIR, which can save the life of patients.
The life saving drugs required for the treatment of Kovid-19 are being prepared in collaboration with leading pharma companies and CSIR. We are also confident in traditional medical systems, as it is better to combine locally relevant research with global recognized scientific principles and achieve better results. It would be difficult to win this war if any of the rescue and offensive measures were ignored. The health system is working to the best of its ability, the research team will have to support it accordingly. We should not shut our eyes even with the search for effective treatment and vaccines, because this is the real solution to this epidemic. 
We have better leadership to inspire the public. In this difficult time, science can guide in creating an effective strategy on the public health front and revitalizing the economy. If we can do this, we will not only end the sufferings of millions of Indians, but will emerge as a strong nation with the help of the supply of products globally.

LEAVE A REPLY

Please enter your comment!
Please enter your name here